Stephen Bustin

Professor Stephen Bustin is a globally recognized academic at Anglia Ruskin University (ARU), holding the position of Professor of Molecular Medicine within the Faculty of Health, Medicine and Social Care. He leads the Molecular Diagnostics Unit at the Medical Technology Research Centre (MTRC), focusing on translating molecular techniques into clinical tools for diagnostics and disease management. His expertise spans quantitative PCR (qPCR), fungal/bacterial pathogen detection, and cancer biomarker research.

Educational Background:

• B.A. (Mod) from Trinity College Dublin
• PhD in Molecular Genetics from Trinity College Dublin

Research Focus: Professor Bustin's work centers on developing cost-effective molecular assays for early infectious disease diagnosis and cancer patient management. Key areas include fungal pathogen identification, antibiotic resistance biomarkers (e.g., MDR-1), and colorectal cancer treatment biomarkers. He advocates for PCR assay reliability through guidelines like MIQE and digital PCR standards.

Publications & Impact: Over 140+ publications, including seminal books on qPCR. His work on qPCR technical standards has been foundational for reproducibility in biomedical research. Recent research emphasizes rapid diagnostic tools and predictive cancer biomarkers.

Awards & Roles:

• Member of the Academy of Europe
• Fellow of the Royal Society of Biology (FRSB)
• Editor-in-Chief of Biomolecular Detection and Quantification

Grants & Collaboration: Led international consortia for MIQE guidelines and contributed expert testimony in landmark legal cases (e.g., MMR vaccine litigation). Current projects focus on aptamer-based diagnostic kits and molecular assays for intraoperative cancer assessments.